A-E Examination: Pelvic Inflammatory Disease
Author – Dr Kalyani Shinkar Editor – Dr James Mackintosh
Last updated 20/08/24
Table of Contents
How to Use
Candidate:
- Read the brief below (1 minute).
- Take a brief history and a perform a A-E examination (10 minute).
- Handover the patient (1 minute)
- Answer viva questions (2 minutes).
Patient/Examiner:
- Familiarise yourself with the history & examination findings
- After completing the history, viva the candidate
Candidate Brief
You are an F1 in A&E. Miss Lola Chapman is a 22-year-old woman who has presented to A&E with severe abdominal pain and abnormal vaginal discharge. Please take a brief history and perform an A-E examination of this patient.
- History
- A-E Examination
- Handover and Viva
Background and Presenting Complaint
- Miss Chapman has a 2-hour history of severe sudden-onset abdominal pain in the left iliac fossa. The pain does not radiate anywhere and is 9/10 in severity. There are no triggering, relieving, or exacerbating factors.
- No nausea or vomiting.
- Feeling feverish
- No changes to bowel habits.
- She reports a 5-day history of dysuria and abnormal vaginal discharge.
- She reports a burning sensation every time she passes urine. She denies any changes to the colour, amount, or frequency of urine. No nocturia or urinary incontinence.
- She has been having increased amounts of offensive green/yellow vaginal discharge. No associated vulvovaginal itching.
- Her last menstrual period was 1 week ago.
- She usually has regular periods. Her cycle length is 28 days. Her periods last 5 days on average. She denies ever having any problems with her periods, including heavy menstrual bleeding, intermenstrual bleeding, dysmenorrhoea, or post-coital bleeding. Menarche occurred at age 12.
- She is currently sexually active and has multiple sexual partners. She has had the progesterone implant for the past 2 years but admits to not using barrier contraception regularly.
- She has never been pregnant. She has not had any terminations or miscarriages in the past.
Past Medical History
- Nil Comorbidities
Drug History and Allergies
- Nil
- NKDA
Introduce yourself, confirm the patient’s identify, and gain consent to examine the patient
- Patient confirms full name and DOB
- She gives consent for you to examine her
End of bed inspection
- She appears to be in severe pain
Airways
- Assess the patency of the patient’s airway, ensure that the patient is able to breathe effectively, and there are no airway obstructions.
- Her airway is patent, as she is able to talk in full sentences
- There are no airway obstructions
Breathing
- Inspect for signs of respiratory compromise (e.g. cyanosis, see-saw breathing, use of accessory muscles, nasal flaring, pursed lip breathing, or increased work of breathing)
- There are no signs of respiratory compromise
- Respiratory rate
- RR = 14
- O2 sats
- O2 sats = 99% on RA
- Palpate for tracheal deviation and symmetrical chest expansion
- Trachea is central and there is symmetrical chest expansion
- Percuss
- Percussion note is resonant throughout
- Auscultate for reduced breath sounds or added sounds
- Vesicular breathing bilaterally
- No added sounds
Circulation
- Inspection (e.g. pale, sweating, clammy)
- Temperature of hands
- Warm and well-perfused
- CRT
- 1 seconds
- Heart Rate
- 104 bpm
- Blood pressure
- 120/80mmHg
- Insert 2 large bore IV cannulae into each antecubital fossae
- Take bloods (FBC to check for raised WCC, U&Es and LFTs for baseline, CRP for infection/inflammation, and blood cultures)
- JVP
- Not raised
- Apex beat
- Palpable in the left 5th ICS midclavicular line
- Heart sounds
- Normal
- Fluid status
- Euvolaemic
- Perform an ECG
- Sinus Rhythm
Disability
- Level of consciousness (AVPU or GCS if a neurological cause for the patient’s presentation is suspected)
- Alert
- Pupils
- Equal and reactive to light
- Blood glucose levels
- 5.0
- Temperature
- 38.0°C
Exposure
- Fully expose the patient by removing their clothing whilst preserving their dignity
- Look for any signs of trauma, swelling, bruises, scars, rashes, or signs of a DVT
- Bimanual examination:
- Cervical motion tenderness
- No abnormal vaginal discharge present
After completing the initial A-E assessment, reassess! Re-assess the patient to identify any additional clinical changes and effectiveness of any interventions you have performed.
1. What are your differential diagnoses?
- Pelvic Inflammatory Disease (due to severe lower abdominal pain, 5-day history of abnormal vaginal discharge and dysuria, and risk factors for PID including young age, multiple sexual partners, and inconsistent use of barrier contraception)
- Ectopic Pregnancy (It’s important to consider ectopic pregnancy in any woman of childbearing age presenting with abdominal pain)
- Ruptured ovarian cyst (important differential diagnosis in a woman presenting with severe abdominal pain)
2. Given a likely diagnosis of Placenta praevia, how would you manage this patient?
- Inform the obstetrics and gynaecology registrar.
- Do a pregnancy test, urine dip, and STI swabs.
- Insert 1 large bore IV cannula and take bloods (FBC, U&Es, LFTs, CRP, blood cultures, and consider testing for HIV and syphilis).
- Prescribe analgesia and commence empiric antibiotic treatment
3. Please Handover this patient to the obstetrics and gynaecology registrar using the SBAR or equivalent format.
- Hi, my name is Dr. Joe Bloggs and I’m calling from A&E. Can I please confirm who I am speaking to?
- I’ve just examined a patient, who I think has acute pelvic inflammatory disease.
- She is a 22-year-old woman called Lola Chapman.
- She has presented with a 2-hour history of severe sudden-onset abdominal pain in the left iliac fossa, which she rates 9/10 in severity. She also has a 5-day history of dysuria and offensive yellow/green vaginal discharge. There is no associated nausea and vomiting.
- Her last menstrual period was 1 week ago.
- She is sexually active and has multiple sexual partners. She uses the progesterone implant as a form of contraception and admits to inconsistent use of barrier contraception.
- She has no comorbidities or allergies.
- On inspection, she appeared to be in severe pain.
- Her airway was patent.
- Her respiratory rate was 14, O2 sats were 99% in room air, and respiratory examination was unremarkable.
- She was haemodynamically stable. I’ve inserted 1 large bore IV cannula and have taken bloods, including FBC, U&Es, LFTs, CRP, and blood cultures.
- She was alert and pyrexial with a temperature of 38°C. Her BM was normal.
- On bimanual examination, there was cervical motion tenderness. There was no vaginal discharge present.
- Can you please come and see her? In the meantime, is there anything you would like me to do?
What is Pelvic Inflammatory Disease?
Pelvic inflammatory disease (PID) is an infection of the upper genital tract (uterus, fallopian tubes, and/or ovaries) in women. It ascends from the lower genital tract (vagina or cervix) and typically develops from sexually transmitted infections (STIs), most commonly Chlamydia trachomatis and Neisseria gonorrhoea. However, in a minority of cases, PID can develop from non-STIs, such as bacterial vaginosis.
Risk Factors
Various risk factors relating to sexual behaviour have been identified:
- Age: Women below the age of 25 are most affected by PID
- Multiple or Recent New Sexual Partners
- Refraining from Barrier Contraception
- History of STIs or PID
- Intrauterine Devices (IUD): There is a small increased risk of PID that is associated with the use of IUDs for contraception.
- Douching: This is the practice of cleaning out the vagina by inserting water or other fluids into the vagina, which can lead to irritation, inflammation, and an increased risk of developing infections.
Clinical Presentation
Some women may be asymptomatic, especially in the early stages of PID, but most commonly symptoms include:
- Lower Abdominal or Pelvic Pain: This is often the most significant symptom of PID. The pain may range from mild to severe, dull to sharp, and may be localised to one side of the abdomen or pelvis. It may radiate to the back and be exacerbated by menstruation or sexual intercourse.
- Abnormal Menstrual Bleeding: PID can cause heavier menstrual bleeding, an increase in period length, intermenstrual bleeding, or post-coital bleeding.
- Abnormal Vaginal Discharge: This may include an increase in volume, unusual colour, or an offensive smell. The discharge may also be associated with vaginal itching.
- Dyspareunia (pain during sexual intercourse)
- Painful Urination: This can occur due to inflammation of the urinary tract.
- Nausea and Vomiting: This can occur due to severe infection or complications such as an abscess or peritonitis.
- Fever: This is a common symptom of PID, but may also occur due to severe infection or complications such as an abscess or peritonitis.
Diagnosis
PID is mainly a clinical diagnosis. Whilst laboratory tests may help to confirm the diagnosis, STI swab test results can take several days to come back. In addition, negative swab results do not exclude a diagnosis of PID. Taking a thorough history and physical examination is therefore crucial for diagnosing PID.
Clinical Assessment:
- History: In addition to asking about medical symptoms, taking a sexual history, asking about contraceptive methods, and assessing for risk factors for PID is important in achieving an accurate diagnosis.
- Bimanual Examination: Abdominal or pelvic tenderness, cervical motion tenderness, and abnormal vaginal discharge are suggestive of PID.
Bedside and Laboratory Tests:
- Pregnancy Test: Any woman of childbearing age presenting with abdominal pain should be considered as ectopic pregnancy until proven otherwise.
- Urine dip: A urine sample should be collected to check for signs of UTI.
- STI Swab Tests: Microscopy of vaginal or cervical discharge and nucleic acid amplification tests (NAAT) are required to assess for Chlamydia trachomatis and Neisseria gonorrhoea.
- Blood Tests: FBC (raised white cell count), U&Es and LFTs for baseline, CRP (infection/inflammation), and blood cultures. Testing for HIV and syphilis should also be considered.
Imaging
- Pelvic ultrasound or CT scan may be considered to evaluate the female reproductive organs for abscesses and assess the extent of the infection.
Management and Complications
Management
- Antibiotics are the mainstay of PID management. A 14-day course of doxycycline, metronidazole, and a single dose of IM ceftriaxone or ofloxacin is the 1st line treatment for outpatient therapy. In severely ill patients, hospitalisation and initial treatment with doxycycline, IV metronidazole, and IV ceftriaxone is recommended before switching to oral treatment with doxycycline and metronidazole to complete 14 days’ treatment. Other indications for hospitalisation include unsuccessful outpatient treatment, complications such as tubo-ovarian abscess, and pregnancy.
- Prevention: It is also important to counsel patients and discuss preventative methods for PID, including practising safe sex (using barrier contraception), regularly testing for STIs, limiting the number of sexual partners, and avoid douching if relevant.
Complications
If left untreated, PID can lead to serious long-term complications, such as chronic pelvic pain, ectopic pregnancy, and infertility.
- https://www.nhs.uk/conditions/pelvic-inflammatory-disease-pid/
- https://www.ncbi.nlm.nih.gov/books/NBK499959/